We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
–
Cap. Flow
+$119M
Cap. Flow %
96.9%
Top 10 Hldgs %
78.47%
Holding
19
New
19
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$14.8M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$13.6M
3
CYH icon
Community Health Systems
CYH
+$12.2M
4
VTRS icon
Viatris
VTRS
+$12.1M
5
OFIX icon
Orthofix Medical
OFIX
+$10M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94.98%
2 Financials 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
1
GSK
GSK
$102B
$15.2M 12.46%
+228,480
New +$14.8M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$36.3B
$13.8M 11.31%
+345,300
New +$13.6M
VTRS icon
3
Viatris
VTRS
$20.1B
$12.8M 10.44%
+294,500
New +$12.1M
CYH icon
4
Community Health Systems
CYH
$392M
$11.5M 9.42%
+355,256
New +$12.2M
OFIX icon
5
Orthofix Medical
OFIX
$443M
$11M 8.96%
+480,800
New +$10M
AMGN icon
6
Amgen
AMGN
$201B
$9.56M 7.81%
+83,800
New +$9.53M
SNY icon
7
Sanofi
SNY
$104B
$6.28M 5.13%
+117,000
New +$6.04M
NVO
8
Novo Nordisk
NVO
$213B
$5.76M 4.71%
+312,000
New +$5.44M
AGN
9
DELISTED
Allergan Inc
AGN
$5.32M 4.35%
+47,900
New +$4.58M
COO icon
10
Cooper Companies
COO
$13.7B
$4.75M 3.88%
+153,600
New +$4.9M
CAH icon
11
Cardinal Health
CAH
$52.9B
$4.64M 3.79%
+69,400
New +$4.24M
IRWD icon
12
Ironwood Pharmaceuticals
IRWD
$624M
$4.46M 3.64%
+458,735
New +$4.12M
ENTA icon
13
Enanta Pharmaceuticals
ENTA
$377M
$4.38M 3.58%
+160,471
New +$3.89M
MGLN
14
DELISTED
Magellan Health Services, Inc.
MGLN
$3.72M 3.04%
+62,100
New +$3.71M
KYTH
15
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$2.95M 2.41%
+79,000
New +$3.28M
EW icon
16
Edwards Lifesciences
EW
$48.3B
$2.68M 2.19%
+244,200
New +$2.75M
AET
17
DELISTED
Aetna Inc
AET
$1.8M 1.47%
+26,300
New +$1.72M
XNPT
18
DELISTED
XENOPORT, INC.
XNPT
$1.39M 1.14%
+241,800
New +$1.31M
RIGL icon
19
Rigel Pharmaceuticals
RIGL
$681M
$341K 0.28%
+11,970
New +$351K

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Senzar Asset Management, which disclosed 19 positions worth $122M. Its ten largest holdings account for 78% of the portfolio.

Its largest position is GSK: 228,480 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Financials.

  • Senzar Asset Management's largest Q4 2013 buy was GSK: 228,480 shares worth $15.2M.
  • Senzar Asset Management's ten largest holdings make up 78% of its $122M portfolio in Q4 2013.
  • Senzar Asset Management disclosed 19 positions in Q4 2013, its first 13F filing on record.

Based on Senzar Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.